Revvityブログ
発見から治療までのイノベーションを促進
Latest
Programmable depletion with CRISPR–Cas9: what DASH is, why it works, and where to use it.
NGS
December 2, 2025 - 4 min read
Disease Research
What to consider when scaling tissue lysis workflows for multi-analyte DNA/RNA workstreams.
December 1, 2025 -
4 min read
NGS
Variant calling through bulk RNA-seq is growing up: implications for oncology introduction.
December 1, 2025 -
3 min read
NGS
Next GeneSiS: cfDNA sequencing outperforms blood culture in sepsis.
December 1, 2025 -
4 min read
NGS
Understanding hybrid capture and the role of universal blockers.
December 1, 2025 -
6 min read
NGS
Challenges in synthetic oligonucleotide production: implications for NGS adapters introduction to NGS adapter synthesis.
December 1, 2025 -
3 min read
Disease Research, High Content Screening Instruments, Cancer, Cancer Research Solutions
High-content conversations: Professor Luca Magnani, Institute of Cancer Research, London.
November 26, 2025 -
3 min read
NGS
Optimal selection of read depth and length for bulk RNA-Seq: an updated perspective.
November 17, 2025 -
3 min read
Drug Development
4 high-content imaging myths every researcher should know.
November 17, 2025 -
1 min read
Cancer
From Nobel recognition to therapeutics screening: the Treg revolution.
November 11, 2025 -
5 min read
Drug Development
Oligonucleotide drug discovery: its journey through time.
November 5, 2025 -
4 min read
